Autoantibodies against different histone H1 subtypes in systemic lupus erythematosus sera. 1990

J Wesierska-Gadek, and E Penner, and H Lindner, and E Hitchman, and G Sauermann
Institute of Tumor Biology-Cancer Research, University of Vienna, Austria.

The H1 histones represent the most heterogenous class of histone proteins. In this study, we analyzed the specificity of human antibodies against 6 H1 subtypes. H1 histones from rat organs were separated by reverse-phase high performance liquid chromatography and used as antigens in immunoblotting experiments. Sera containing anti-histone H1 antibodies were obtained from patients with systemic lupus erythematosus. Of the 9 sera tested, 2 reacted with only 1 H1 subtype. The other sera recognized different combinations of H1 subtypes. Only 1 serum reacted with all 6 H1 subtypes. Histones H1.5 and H1.1 were the subtypes most frequently recognized by the human autoantibodies. Our data indicate that human anti-H1 antibodies represent a heterogenous population, directed mainly against epitopes localized in the variable region of the H1 molecule.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D006657 Histones Small chromosomal proteins (approx 12-20 kD) possessing an open, unfolded structure and attached to the DNA in cell nuclei by ionic linkages. Classification into the various types (designated histone I, histone II, etc.) is based on the relative amounts of arginine and lysine in each. Histone,Histone H1,Histone H1(s),Histone H2a,Histone H2b,Histone H3,Histone H3.3,Histone H4,Histone H5,Histone H7
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D015151 Immunoblotting Immunologic method used for detecting or quantifying immunoreactive substances. The substance is identified by first immobilizing it by blotting onto a membrane and then tagging it with labeled antibodies. Dot Immunoblotting,Electroimmunoblotting,Immunoelectroblotting,Reverse Immunoblotting,Immunoblotting, Dot,Immunoblotting, Reverse,Dot Immunoblottings,Electroimmunoblottings,Immunoblottings,Immunoblottings, Dot,Immunoblottings, Reverse,Immunoelectroblottings,Reverse Immunoblottings

Related Publications

J Wesierska-Gadek, and E Penner, and H Lindner, and E Hitchman, and G Sauermann
September 1992, Molecular biology reports,
J Wesierska-Gadek, and E Penner, and H Lindner, and E Hitchman, and G Sauermann
October 2016, Arthritis research & therapy,
J Wesierska-Gadek, and E Penner, and H Lindner, and E Hitchman, and G Sauermann
December 1993, Behring Institute Mitteilungen,
J Wesierska-Gadek, and E Penner, and H Lindner, and E Hitchman, and G Sauermann
May 2004, Medical science monitor : international medical journal of experimental and clinical research,
J Wesierska-Gadek, and E Penner, and H Lindner, and E Hitchman, and G Sauermann
February 2014, Biochimie,
J Wesierska-Gadek, and E Penner, and H Lindner, and E Hitchman, and G Sauermann
November 2003, Clinical and experimental immunology,
J Wesierska-Gadek, and E Penner, and H Lindner, and E Hitchman, and G Sauermann
January 2018, Frontiers in immunology,
J Wesierska-Gadek, and E Penner, and H Lindner, and E Hitchman, and G Sauermann
January 2021, Clinical & translational immunology,
J Wesierska-Gadek, and E Penner, and H Lindner, and E Hitchman, and G Sauermann
September 1994, Current opinion in rheumatology,
J Wesierska-Gadek, and E Penner, and H Lindner, and E Hitchman, and G Sauermann
April 1988, Annals of the Academy of Medicine, Singapore,
Copied contents to your clipboard!